DR. JOSEPH A. PIZZANO M.D.
Prescription History 1154390607
Ophthalmology in Jenkintown, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JOSEPH A. PIZZANO M.D., an active Ophthalmology specialist practicing in Jenkintown, PA. Our medical registry currently tracks 26 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,306 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 624 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Latanoprost | 624 | $14.28 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 624 Medicare prescriptions for Latanoprost, about 4.7 times the volume of the typical Pennsylvania prescriber of this medication (132.2). Medicare paid an average of $14.28 per fill, versus $12.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,395 30-Day Fills standardized to 30-day supplies 41,049 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 269 | $13.73▼ below PA avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 269 Medicare prescriptions for Timolol Maleate, about 3.8 times the volume of the typical Pennsylvania prescriber of this medication (71.6). Medicare paid an average of $13.73 per fill, versus $20.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 639.6 30-Day Fills standardized to 30-day supplies 19,081 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 172 | $506.62 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 172 Medicare prescriptions for Lumigan, about 2.5 times the volume of the typical Pennsylvania prescriber of this medication (67.6). Medicare paid an average of $506.62 per fill, versus $462.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 344.9 30-Day Fills standardized to 30-day supplies 9,886 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 156 | $14.00▼ below PA avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 156 Medicare prescriptions for Dorzolamide-Timolol, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (85.1). Medicare paid an average of $14.00 per fill, versus $21.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 343.4 30-Day Fills standardized to 30-day supplies 10,302 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 115 | $70.59 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 115 Medicare prescriptions for Brimonidine Tartrate, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (66.1). Medicare paid an average of $70.59 per fill, versus $53.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 265.4 30-Day Fills standardized to 30-day supplies 7,882 Days of Medication total across all patients in 2024 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 113 | $35.08▼ below PA avg | ▲ More than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 113 Medicare prescriptions for Tobramycin-Dexamethasone, about 3.2 times the volume of the typical Pennsylvania prescriber of this medication (35.6). Medicare paid an average of $35.08 per fill, versus $40.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 116.7 30-Day Fills standardized to 30-day supplies 2,436 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 111 | $49.39 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 111 Medicare prescriptions for Prednisolone Acetate, about 88% of the volume of the typical Pennsylvania prescriber of this medication (126.2). Medicare paid an average of $49.39 per fill, versus $38.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 156 30-Day Fills standardized to 30-day supplies 4,186 Days of Medication total across all patients in 2024 | |||
| Dorzolamide Hcl | 89 | $18.48▼ below PA avg | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor. In 2024, this provider wrote 89 Medicare prescriptions for Dorzolamide Hcl, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (49). Medicare paid an average of $18.48 per fill, versus $20.36 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 158.4 30-Day Fills standardized to 30-day supplies 4,737 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 89 | $1,249.83 | ▲ More than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 89 Medicare prescriptions for Restasis, about 2.1 times the volume of the typical Pennsylvania prescriber of this medication (41.6). Medicare paid an average of $1,249.83 per fill, versus $975.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 191 30-Day Fills standardized to 30-day supplies 5,715 Days of Medication total across all patients in 2024 | |||
| Cyclosporine | 75 | $654.77 | ▲ More than typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 75 Medicare prescriptions for Cyclosporine, about 2.2 times the volume of the typical Pennsylvania prescriber of this medication (34.3). Medicare paid an average of $654.77 per fill, versus $509.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 164 30-Day Fills standardized to 30-day supplies 4,920 Days of Medication total across all patients in 2024 | |||
| Travoprost | 69 | $203.99 | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 69 Medicare prescriptions for Travoprost, about 2.1 times the volume of the typical Pennsylvania prescriber of this medication (32.8). Medicare paid an average of $203.99 per fill, versus $183.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 128.3 30-Day Fills standardized to 30-day supplies 3,750 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 63 | $240.90 | ▲ More than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. In 2024, this provider wrote 63 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (37.3). Medicare paid an average of $240.90 per fill, versus $183.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 138.8 30-Day Fills standardized to 30-day supplies 4,059 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 61 | $419.84 | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 61 Medicare prescriptions for Combigan, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (34.3). Medicare paid an average of $419.84 per fill, versus $362.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 102.2 30-Day Fills standardized to 30-day supplies 2,990 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 55 | $11.60▼ below PA avg | ≈ Typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 55 Medicare prescriptions for Erythromycin, about the same volume as the typical Pennsylvania prescriber of this medication (49). Medicare paid an average of $11.60 per fill, versus $17.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 57 30-Day Fills standardized to 30-day supplies 866 Days of Medication total across all patients in 2024 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 44 | $701.18 | ≈ Typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2024, this provider wrote 44 Medicare prescriptions for Rocklatan, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (38.1). Medicare paid an average of $701.18 per fill, versus $494.73 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 90.9 30-Day Fills standardized to 30-day supplies 2,641 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 30 | $11.62▼ below PA avg | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 30 Medicare prescriptions for Ketorolac Tromethamine, about a third of the volume of the typical Pennsylvania prescriber of this medication (92.3). Medicare paid an average of $11.62 per fill, versus $16.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 39.7 30-Day Fills standardized to 30-day supplies 1,088 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 27 | $941.98▼ below PA avg | ≈ Typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 27 Medicare prescriptions for Xiidra, about 77% of the volume of the typical Pennsylvania prescriber of this medication (35.3). Medicare paid an average of $941.98 per fill, versus $1,076.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
| Fluorometholone | 23 | $96.00 | ▼ Less than typical |
About Fluorometholone: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) In 2024, this provider wrote 23 Medicare prescriptions for Fluorometholone, about 60% of the volume of the typical Pennsylvania prescriber of this medication (38.2). Medicare paid an average of $96.00 per fill, versus $84.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 1,220 Days of Medication total across all patients in 2024 | |||
| Loteprednol Etabonate | 21 | $251.26 | ▼ Less than typical |
About Loteprednol Etabonate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ It is also used after eye surgery. Loteprednol works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2024, this provider wrote 21 Medicare prescriptions for Loteprednol Etabonate, about 75% of the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $251.26 per fill, versus $167.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28.1 30-Day Fills standardized to 30-day supplies 822 Days of Medication total across all patients in 2024 | |||
| Brinzolamide | 19 | $214.52▼ below PA avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. An antiglaucoma agent. In 2024, this provider wrote 19 Medicare prescriptions for Brinzolamide, about 63% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $214.52 per fill, versus $223.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 38.7 30-Day Fills standardized to 30-day supplies 1,160 Days of Medication total across all patients in 2024 | |||
| Ofloxacin | 15 | $13.48▼ below PA avg | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2024, this provider wrote 15 Medicare prescriptions for Ofloxacin, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (59). Medicare paid an average of $13.48 per fill, versus $14.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 16.9 30-Day Fills standardized to 30-day supplies 401 Days of Medication total across all patients in 2024 | |||
| RhopressaNetarsudil Mesylate | 14 | $309.54▼ below PA avg | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. A Rho kinase inhibitor with norepinephrine transport inhibitory activity that reduces production of aqueous humor. In 2024, this provider wrote 14 Medicare prescriptions for Rhopressa, about a third of the volume of the typical Pennsylvania prescriber of this medication (44.1). Medicare paid an average of $309.54 per fill, versus $469.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 14 30-Day Fills standardized to 30-day supplies 350 Days of Medication total across all patients in 2024 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 14 | $196.57▼ below PA avg | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2024, this provider wrote 14 Medicare prescriptions for Simbrinza, about half the volume of the typical Pennsylvania prescriber of this medication (31.6). Medicare paid an average of $196.57 per fill, versus $262.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 15.3 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Lotemax SmLoteprednol Etabonate | 13 | $251.36▼ below PA avg | ▼ Less than typical |
About Lotemax Sm: This medication is used to treat eye inflammation and pain after eye surgery. Show more ▾ Loteprednol works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2024, this provider wrote 13 Medicare prescriptions for Lotemax Sm, about half the volume of the typical Pennsylvania prescriber of this medication (30.5). Medicare paid an average of $251.36 per fill, versus $289.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| VyzultaLatanoprostene Bunod | 13 | $247.09▼ below PA avg | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. A lanatoprost prodrug, nitric oxide donor, and PGF2alpha agonist. In 2024, this provider wrote 13 Medicare prescriptions for Vyzulta, about a third of the volume of the typical Pennsylvania prescriber of this medication (34.7). Medicare paid an average of $247.09 per fill, versus $428.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 14.3 30-Day Fills standardized to 30-day supplies 385 Days of Medication total across all patients in 2024 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $11.75 | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 12 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (44.9). Medicare paid an average of $11.75 per fill, versus $11.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 129 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. JOSEPH A. PIZZANO M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Jenkintown, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
